Kaposi's sarcoma after allogeneic bone marrow transplantation in a child.

1. Montella M, Crispo Apezzullo L, Izzo F, Fabbrocini G, Ronga D, Tamburini M. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. Int J Cancer 2000; (in press). 2. Perez Sanchez I, Rivera Redondo J, Garcia Manforte A, Mayoayo Crespo M, Escudero Soto A, Pintado Cros T. B-lymphoproliferative disorders in patients with hepatitis C virus infection. Haematologica 1998; 83:946-8. 3. Domingo JM, Romero S, Moreno JA, Domingo JA, Callen L, Gutierrez M. Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases. Haematologica 1999; 84:94-6. 4. Ferri C, La Civita L, Zignego AL, Pasero G. Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Invest 1997; 27:711-8. 5. Bataille R, Harousseau JL. Multiple myeloma. New Engl J Med 1997; 336:1657-64. 6. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi’s Sarcomaassociated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276:1851-4. 7. Rosemberg W. Mechanisms of immune escape in viral hepatitis. Gut 1999; 44:759-64. 8. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26:1006-11. 9. Montella M, Bidoli E, De Marco MR, et al. High mortality rates from liver cancer in the urban area of Campania Region: prevalence of hepatitis and sociodemographic factors. Oncol Rep 1998; 5:165-9. 10. Masala G, Di Lollo S, Picoco C, et al. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes. Int J Cancer 1996; 68:156-9.